Cleared Traditional

K792185 - PIASMA SAFE

K792185 is the FDA 510(k) clearance for PIASMA SAFE by Cry-O-Safe, Inc.. It is a Class 2 Hematology device (product code KSR) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K792185 · Cry-O-Safe, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1979
Decision
58d
Days
Class 2
Risk

K792185 is an FDA 510(k) clearance for the PIASMA SAFE. Classified as Container, Empty, For Collection & Processing Of Blood & Blood Components (product code KSR), Class II - Special Controls.

Submitted by Cry-O-Safe, Inc. (Mchenry, US). The FDA issued a Cleared decision on December 28, 1979 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.9100 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cry-O-Safe, Inc. devices

Submission Details

510(k) Number K792185 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 1979
Decision Date December 28, 1979
Days to Decision 58 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 113d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KSR Container, Empty, For Collection & Processing Of Blood & Blood Components
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.9100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - KSR Container, Empty, For Collection & Processing Of Blood & Blood Components

All 7
Devices cleared under the same product code (KSR) and FDA review panel - the closest regulatory comparables to K792185.
HAEMONETICS 600 ML. COMPONENT BAG
K810711 · Haemonetics Corp. · May 1981
HAEMONETICS 1400 ML THERAPEUTIC BAG
K810313 · Haemonetics Corp. · Mar 1981
GAMBRO HEMOFREEZE-BAG
K801082 · Gambro, Inc. · Oct 1980
TRANSFER PAK 4R 9006
K781811 · Travenol Laboratories, S.A. · Nov 1978
CRYOCYTE PACK
K780354 · Travenol Laboratories, S.A. · Jun 1978